Galera Therapeutics Inc (GRTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2 WEST LIBERTY BLVD #100 MALVERN, PA 19355

Galera Therapeutics, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapeutics to improve both the tolerability of current anti-cancer treatments and directly treat cancer. Galera Therapeutics serves healthcare sector in the United States.

Data as of 2021-05-08 12:05:16 -0400
Market Cap153.545 Million Shares Outstanding25.254 Million Avg 30-day Volume1.55 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.07 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.97047 52-week High/Low15.0 / 5.96 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from GRTX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 52 45 15.56% 18 (1.08%) 14 (0.87%) 28.57%
13F shares: 19.277 Million 18.816 Million 2.45% 7.155 Million 6.625 Million 8.0%
% Ownership 77.2566 75.41 2.45% 28.6768 26.5534 8.0%
New Positions: 8 5 60.0% 5 3 66.67%
Increased Positions 20 7 185.71% 6 2 200.0%
Closed Positions 1 2 -50.0% 1 1 0.0%
Reduced Positions 8 14 -42.86% 2 3 -33.33%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

217 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SORENSEN MEL PRESIDENT AND CEO

  • Officer
  • Director
232,044 2021-03-26 2

NOVO HOLDINGS A/S

  • 10% Owner
2,459,021 2021-02-18 2

BEARDSLEY ROBERT A CHIEF OPERATING OFFICER

  • Officer
0 2021-01-26 1

FRATAMICO ARTHUR CHIEF BUSINESS OFFICER

  • Officer
0 2021-01-26 1

SUSSMAN JOEL F. CHIEF ACCOUNTING OFFICER

  • Officer
0 2021-01-26 2

HOLMLUND JON T CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-26 5

DEGNAN CHRIS CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-26 1

ALLEVA LAWRENCE M

  • Director
6,325 2020-11-13 2

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • FORMER 10% OWNERFORMER 10% OWNER
2,467,961 2020-06-18 3

CUNNINGHAM EMMETT

  • Director
0 2020-06-09 1

LOKAY KEVIN G

  • Director
0 2020-06-09 1

POWELL MICHAEL

  • Director
  • 10% Owner
0 2020-06-09 1

WEST LINDA

  • Director
0 2020-03-31 0

RILEY DENNIS CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-01-31 0

SOFINNOVA VENTURE PARTNERS IX, L.P.

SOFINNOVA MANAGEMENT IX, L.L.C.

POWELL MICHAEL

HEALY JAMES

MEHRA ANAND

  • Director
  • 10% Owner
3,083,712 2019-11-12 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

SONSINI PETER W.

KERINS PATRICK J

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

BARRIS PETER J

BASKETT FOREST

FLORENCE ANTHONY A. JR.

MOTT DAVID M

SANDELL SCOTT D

  • 10% Owner
4,358,047 2019-11-12 0

BLACKSTONE CLARUS GP L.P.

BLACKSTONE CLARUS GP L.L.C.

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE HOLDINGS I/II GP L.L.C.

BLACKSTONE GROUP INC

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
3,107,968 2019-11-12 0

CLARUS IV-A, L.P.

CLARUS IV-B, L.P.

CLARUS IV-C, L.P.

CLARUS IV-D, L.P.

CLARUS IV GP L.P.

  • 10% Owner
3,107,968 2019-11-12 0

ROSS STEPHEN A

  • 10% Owner
0 2019-11-06 0

FULLER JASON

  • Director
0 2019-11-06 0

SCHALL OTTO

  • 10% Owner
0 2019-11-06 0

BUCKLER REGINA A.

  • 10% Owner
54,258 2019-11-06 0

WOOD BRIAN

  • 10% Owner
0 2019-11-06 0

BRILL JEFFREY

  • 10% Owner
0 2019-11-06 0

MATTHES CATHERINE L.

  • 10% Owner
52,830 2019-11-06 0

KEENE JEFFREY

  • 10% Owner
54,258 2019-11-06 0

BLACKSTONE GROUP INC

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
0 2019-11-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SORENSEN MEL - Director - Officer PRESIDENT AND CEO

2021-03-30 16:42:15 -0400 2021-03-26 M 170,075 $1.07 a 185,104 direct -0.7937 -6.3492 0.7937 3 -6.6893 5

SORENSEN MEL - Director - Officer PRESIDENT AND CEO

2021-03-30 16:42:15 -0400 2021-03-26 M 170,075 d 0 direct

SORENSEN MEL - Director - Officer PRESIDENT AND CEO

2021-03-30 16:42:15 -0400 2021-03-26 M 46,940 $1.14 a 232,044 direct -0.7937 -6.3492 0.7937 3 -6.6893 5

SORENSEN MEL - Director - Officer PRESIDENT AND CEO

2021-03-30 16:42:15 -0400 2021-03-26 M 46,940 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GALERA THERAPEUTICS INC GRTX 2021-05-10 22:15:04 UTC -1.5434 1.5934 20000
GALERA THERAPEUTICS INC GRTX 2021-05-10 21:45:02 UTC -1.5434 1.5934 20000
GALERA THERAPEUTICS INC GRTX 2021-05-10 21:15:02 UTC -1.5434 1.5934 20000
GALERA THERAPEUTICS INC GRTX 2021-05-10 20:45:03 UTC -1.5434 1.5934 20000
GALERA THERAPEUTICS INC GRTX 2021-05-10 20:15:03 UTC -1.5434 1.5934 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 19:45:03 UTC -1.5434 1.5934 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 19:15:03 UTC -1.5434 1.5934 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 18:45:03 UTC -1.5405 1.5905 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 18:15:03 UTC -1.5405 1.5905 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 17:45:02 UTC -1.5405 1.5905 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 17:15:03 UTC -1.5405 1.5905 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 16:45:03 UTC -1.5365 1.5865 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 16:15:03 UTC -1.5365 1.5865 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 15:45:03 UTC -1.5365 1.5865 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 15:15:03 UTC -1.5365 1.5865 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 14:45:04 UTC -1.5369 1.5869 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 14:15:04 UTC -1.5369 1.5869 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 13:45:04 UTC -1.5369 1.5869 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 13:15:03 UTC -1.5369 1.5869 25000
GALERA THERAPEUTICS INC GRTX 2021-05-10 12:45:02 UTC -1.5369 1.5869 25000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments